Evidence map›Paper›PMID 31850627›Full record

ReviewPeriodontology 20002020

Periodontal inflammation: Integrating genes and dysbiosis.

Shaoping Zhang, Ning Yu, Roger M Arce

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Periodontology 2000, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06041178 (Efficiency of Flurbiprofen 2.5% in Comparison to 98% Aloe Vera Gel as an Adjunctive Therapy to Scaling and Root Planning in the Initial Treatment of Stage III Chronic Periodontitis in Smoking Patients), which is not on this map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06041178 phase4completednot on this mapstarted 2022, after this paper: background citation

Efficiency of Flurbiprofen 2.5% in Comparison to 98% Aloe Vera Gel as an Adjunctive Therapy to Scaling and Root Planning in the Initial Treatment of Stage III Chronic Periodontitis in Smoking Patients

TypeinterventionalSponsorBeirut Arab UniversityRan2022 to 2023Enrolled60ConditionsPeriodontitis Chronic Generalized SevereArms2.5% flurbiprofen, 98% aloe vera, Placebo
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Periodontal diseases in Africa.Periodontology 2000 · 2025
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Shaoping ZhangPeriodontics Department, College of Dentistry, University of Iowa, Iowa City, Iowa, USA.
Ning YuApplied Oral Science Department, The Forsyth Institute, Cambridge, Massachusetts, USA.
Roger M ArceDepartment of Periodontics, Dental College of Georgia, Augusta University, Augusta, Georgia, USA.
Augusta University · USUniversity of Iowa · US

Funding

Investigating the role of Tumor Necrosis Factor-Receptor Associated Factor 3 Interacting Protein 2 R00DE027086 · NIDCR · UNIVERSITY OF IOWA · PI ZHANG, SHAOPING · 2019 to 2021
$735k
GENOME-WIDE ASSOCIATION STUDY OF PERIODONTAL DISEASER01DE021418 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI OFFENBACHER, STEVEN · 2011 to 2012
$658k
Investigating the role of Tumor Necrosis Factor-Receptor Associated Factor 3 Interacting Protein 2 (TRAF3IP2), a critical adaptor in IL-17 pathway, in periodontal diseaseK99DE027086 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZHANG, SHAOPING · 2017 to 2018
$231k
NIDCR NIH HHS K99 DE027086NIDCR NIH HHS K99DE027086NIDCR NIH HHS R00 DE027086NIDCR NIH HHS R01 DE021418
6 · The paper itself

Abstract

Biofilm bacteria co-evolve and reach a symbiosis with the host on the gingival surface. The disruption of the homeostatic relationship between plaque bacteria and the host can initiate and promote periodontal disease progression. Recent advances in sequencing technologies allow researchers to profile disease-associated microbial communities and quantify microbial metabolic activities and host transcriptional responses. In addition to confirming the findings from previous studies, new putative pathogens and novel genes that have not previously been associated with periodontitis, emerge. For example, multiple studies have reported that Synergistetes bacteria are associated with periodontitis. Genes involved in epithelial barrier defense were downregulated in periodontitis, while excessive expression of interleukin-17 was associated with a hyperinflammatory response in periodontitis and with a unique microbial community. Bioinformatics-enabled gene ontology pathway analyses provide a panoramic view of the bacterial and host activities as they shift from periodontal health to disease. Additionally, host innate factors, such as genetic variants identified by either a candidate-gene approach or genome-wide association analyses, have an impact on subgingival bacterial colonization. Transgenic mice carrying candidate genetic variants, or with the deletion of candidate genes mimicking the deleterious loss-of-function variant effect, provide experimental evidence validating the biologic relevance of the novel markers associated with the microbial phenotype identified through a statistical approach. Further refinement in bioinformatics, data management approaches, or statistical tools, are required to gain insight into host-microbe interactions by harmonizing the multidimensional "big" data at the genomic, transcriptional, and proteomic levels.

Indexed as

DysbiosisPeriodontitisAnimalsGenome-Wide Association StudyHumansInflammationMiceProteomicsgenome-wide association study (GWAS)inflammationmicrobiomeperiodontitistranscriptome

Identifiers

PMID31850627
PMCPMC6924568
OpenAlexW2996226328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.